Professor Michael Kleiner Shochat

Hillel Yaffe Medical Center, Hadera (Israel)

Follow

Biography

Engineer in electronics and medical devices. Since 2012 Professor in Cardiology and Director Heart Failure Unit in Hillel Yaffe hospital in Israel.

Contributor content

Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: Insights From the IMPEDANCE-HF Trial

Presentation

Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: Insights From the IMPEDANCE-HF Trial

Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial

Presentation

Monitoring of the lung fluid status in hospitalized COVID-19 patients for predicts outcome. Results of the IMPEDANCE-Corona Trial

COVID-IMPEDANCE trial - Using lung impedance technique for monitoring
COVID19 patients

Presentation

COVID-IMPEDANCE trial - Using lung impedance technique for monitoring COVID19 patients

Problem of 30-day readmission for Heart Failure could be improved. Results of IMPEDANCE-HF extended trial

Presentation

Problem of 30-day readmission for Heart Failure could be improved. Results of IMPEDANCE-HF extended trial

Residual congestion on discharge for Heart Failure assessed by impedance technique predicts 30-day and one-year All-cause death. Results of IMPEDANCE-HF extended trial

Presentation

Residual congestion on discharge for Heart Failure assessed by impedance technique predicts 30-day and one-year All-cause death. Results of IMPEDANCE-HF extended trial

Compeering of predictive accuracy for 30, 90 and 365-day Heart Failure readmission assessed by impedance technique and NT-proBNP. Results of IMPEDANCE-HF extended trial

Presentation

Compeering of predictive accuracy for 30, 90 and 365-day Heart Failure readmission assessed by impedance technique and NT-proBNP. Results of IMPEDANCE-HF extended trial

Residual congestion on discharge for Heart Failure assessed by impedance technique predicts 30-day and one-year Heart Failure death. Results of IMPEDANCE-HF extended trial

Presentation

Residual congestion on discharge for Heart Failure assessed by impedance technique predicts 30-day and one-year Heart Failure death. Results of IMPEDANCE-HF extended trial

Prediction of 30-day readmission for Heart Failure by N-terminal pro-brain natriuretic peptides. Results of IMPEDANCE-HF extended trial

Presentation

Prediction of 30-day readmission for Heart Failure by N-terminal pro-brain natriuretic peptides. Results of IMPEDANCE-HF extended trial

Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial)

Presentation

Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial)

Thirty day and one-year risk stratification of Heart Failure Death According N-terminal pro-brain natriuretic peptide at discharge for Heart Failure hospitalization. Results of IMPEDANCE-HF extended t

Presentation

Thirty day and one-year risk stratification of Heart Failure Death According N-terminal pro-brain natriuretic peptide at discharge for Heart Failure hospitalization. Results of IMPEDANCE-HF extended t

ESC 365 is supported by

novartis

Explore sponsored resources